What is NDC 0904-5448?

0904-5448 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Major Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.

Major Pharmaceuticals, NDC labeler code 0904. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pentoxifylline?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pentoxifylline NDC 0904-5448 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0904-5448Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00904-5448Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0904-5448-61	00904544861	100 BLISTER PACK in 1 CARTON (0904-5448-61) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Jun 10, 1999

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pentoxifylline
Generic name (nonproprietary): pentoxifylline
Active ingredients: Pentoxifylline — 400 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Major PharmaceuticalsNDC labeler code 0904
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075191
Marketing start: Jun 10, 1999
Listing expires: Dec 31, 2026
Other FDA classes: Hematologic Activity Alteration (Physiologic effect)
Identifiers: Product ID 0904-5448_e41391a6-e956-41ab-8169-45f6e48d4fa2SPL ID e41391a6-e956-41ab-8169-45f6e48d4fa2SPL set ID 59c9a583-1f93-480f-879c-457a574374daRxCUI 312301UNII SD6QCT3TSU
Pharmacologic class: Blood Viscosity Reducer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400904544861 followed by a unit qualifier and the quantity

Package 00904-5448-61. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 22, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0904-5448

What is NDC 0904-5448?: 0904-5448 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Major Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pentoxifylline.
What is the active ingredient?: Pentoxifylline.
Who is the labeler?: Major Pharmaceuticals, NDC labeler code 0904. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pentoxifylline?: 7 other product NDCs are listed under this name. See all Pentoxifylline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pentoxifylline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Pentoxifylline	Pentoxifylline 400 mg/1	TabletOral	Advagen Pharma Ltd.,	72888-268	72888-0268-0172888-0268-0272888-0268-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-2586	71335-2586-0171335-2586-0271335-2586-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-856	16571-0856-0116571-0856-0516571-0856-11+2 more
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8511	00615-8511-39
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	ANI Pharmaceuticals, Inc.	70954-668	70954-0668-1070954-0668-20
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Apotex Corp.	60505-0033	60505-0033-0660505-0033-07
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-2910	63629-2910-0163629-2910-0263629-2910-03

Other NDCs under ANDA 075191

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075191
Product	Strength	Form · route	Labeler	Product NDC
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Apotex Corp.	60505-0033
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-2910